Metaplasia (or transdifferentiation) is defined as the transformation of one tissue type to another. Clues to the molecular mechanisms that control the development of metaplasia are implied from knowledge of the transcription factors that specify tissue identity during normal embryonic development. Barrett's metaplasia describes the development of a columnar/intestinal phenotype in the squamous oesophageal epithelium and is the major risk factor for oesophageal adenocarcinoma. This particular type of cancer has a rapidly rising incidence and a dismal prognosis. The homoeotic transcription factor Cdx2 (Caudal-type homeobox 2) has been implicated as a master switch gene for intestine and therefore for Barrett's metaplasia. Normally, Cdx2 expression is restricted to the epithelium of the small and large intestine. Loss of Cdx2 function, or conditional deletion in the intestine, results in replacement of intestinal cells with a stratified squamous phenotype. In addition, Cdx2 is sufficient to provoke intestinal metaplasia in the stomach. In the present paper, we review the evidence for the role of Cdx2 in the development of Barrett's metaplasia.
Skip Nav Destination
Conference Article| March 22 2010
The role of Cdx2 in Barrett's metaplasia
Benjamin J. Colleypriest;
Benjamin J. Colleypriest 1
*Centre for Regenerative Medicine, Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K.
1To whom correspondence should be addressed (email Bcolleypriest@doctors.net.uk).
Search for other works by this author on:
J. Mark Farrant;
Jonathan M.W. Slack;
- Views Icon Views
- Share Icon Share
Benjamin J. Colleypriest, J. Mark Farrant, Jonathan M.W. Slack, David Tosh; The role of Cdx2 in Barrett's metaplasia. Biochem Soc Trans 1 April 2010; 38 (2): 364–369. doi: https://doi.org/10.1042/BST0380364
Download citation file:
Don't already have an account? Register
Get Access To This Article
Buy This Article